Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 1, 2011, Pages 71-76

  Hayashi, Mikihito ^a   Matsumoto, Naoki ^a   Takenoshita Nakaya, Sachiko ^a   Takeba, Yuko ^a   Watanabe, Minoru ^a   Kumai, Toshio ^a   Takagi, Masayuki ^a   Tanaka, Masami ^a   Otsubo, Takehito ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 hydroxylansoprazolation; Cytochrome P450 2C19; Japanese; Lansoprazole; Small intestine

Indexed keywords

CYTOCHROME P450 2C19; LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; HYDROXYLATION; INTESTINE CELL; JAPANESE; LAMINA PROPRIA; LIVER MICROSOME; MAJOR CLINICAL STUDY; MALE; METABOLIC CAPACITY; MICROSOME; PANCREATICODUODENECTOMY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL INTESTINE MICROSOME; SMALL INTESTINE MUCOSA; TISSUE DISTRIBUTION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; HYDROXYLATION; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICROSOMES; MIDDLE AGED; PANCREATICODUODENECTOMY; PROTEIN TRANSPORT;

EID: 78951486317     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.71     Document Type: Article

References (31)

1. Löfgren S., Baldwin R. M., Hiratsuka M., Lindqvist A., Carlberg A., Sim S. C., Schülke M., Snait M., Edenro A., Fransson-Steen R., Terelius Y., Ingelman-Sundberg M., Drug Metab. Dispos., 36, 55-962 (2008).
2. Glaeser H., Drescher S., van der Kuip H., Behrens C., Geick A., Burk O., Dent J., Somogyi A., Von Richter O., Griese E. U., Eichelbaum M., Fromm M. F., Clin. Pharmacol. Ther., 71, 131-140 (2002).
3. Klose T. S., Blaisdell J. A., Goldstein J. A., J. Biochem. Mol. Toxicol., 13, 289-295 (1999).
4. Zhang Q. Y., Dunbar D., Ostrowska A., Zeisloft S., Yang J., Kaminsky L. S., Drug Metab. Dispos., 27, 804-809 (1999).
5. Kolars J. C., Schmiedlin-Ren P., Schuetz J. D., Fang C., Watkins P. B., J. Clin. Invest., 90, 1871-1878 (1992).
6. Obach R. S., Zhang Q. Y., Dunbar D., Kaminsky L. S., Drug Metab. Dispos., 29, 347-352 (2001).
7. Paine M. F., Hart H. L., Ludington S. S., Haining R. L., Rettie A. E., Zeldin D. C., Drug Metab. Dispos., 34, 880-886 (2006).
8. Chaudhry A. S., Kochhar R., Kohli K. K., Indian J. Med. Res., 127, 521-530 (2008).
9. Miura M., Yakugaku Zasshi, 126, 395-402 (2006).
10. von Moltke L. L., Greenblatt D. J., Grassi J. M., Granda B. W., Venkatakrishnan K., Duan S. X., Fogelman S. M., Harmatz J. S., Shader R. I., Biol. Psychiatr., 46, 839-849 (1999).
11. Wu M., Chen S., Wu X., Med. Sci. Monit., 12, 174-178 (2006).
12. Furuta T., Shirai N., Sugimoto M., Nakamura A., Hishida A., Ishizaki T., Drug Metab. Pharmacokinet., 20, 153-167 (2005).
13. Läpple F., von Richter O., Fromm M. F., Richter T., Thon K. P., Wisser H., Griese E. U., Eichelbaum M., Kivistö K. T., Pharmacogenetics, 13, 565-575 (2003).
14. de Morais S. M., Wilkinson G. R., Blaisdell J., Meyer U. A., Nakamura K., Goldstein J. A., Mol. Pharmacol., 46, 594-598 (1994).
15. Pearce R. E, Rodrigues A. D., Goldstein J. A., Parkinson A., J. Pharmacol. Exp. Ther., 277, 805-816 (1996).
16. Yanagida Y., Watanabe M., Takeba Y., Kumai T., Matsumoto N., Hayashi M., Suzuki S., Kinoshita Y., Kobayashi S., Biol. Pharm. Bull., 32, 1422-1426 (2009).
17. Ko J. W., Sukhova N., Thacker D., Chen P., Flockhart D. A., Drug Metab. Dispos., 25, 853-862 (1997).
18. Li X. Q., Andersson T. B., Ahlström M., Weidolf L., Drug Metab. Dispos., 32, 821-827 (2004).
19. Yokose T., Doy M., Taniguchi T., Shimada T., Kakiki M., Horie T., Matsuzaki Y., Mukai K., Virchows Arch., 434, 401-411 (1999).
20. Mamiya K., Ieiri I., Shimamoto J., Yukawa E., Imai J., Ninomiya H., Yamada H., Otsubo K., Higuchi S., Tashiro N., Epilepsia, 39, 1317-1323 (1998).
21. Parkinson A., Mudra D. R., Johnson C., Dwyer A., Carroll K. M., Toxicol. Appl. Pharmacol., 15, 193-209 (2004).
22. Hamdy S. I., Hiratsuka M., Narahara K., El-Enany M., Moursi N., Ahmed M. S., Mizugaki M., Br. J. Clin. Pharmacol., 53, 596-603 (2002).
23. de Morais S. M., Wilkinson G. R., Blaisdell J., Nakamura K., Meyer U. A., Goldstein J. A., J. Biol. Chem., 269, 15419-15422 (1994).
24. Ozawa S., Soyama A., Saeki M., Fukushima-Uesaka H., Itoda M., Koyano S., Sai K., Ohno Y., Saito Y., Sawada J., Drug Metab. Pharmacokinet., 19, 83-95 (2004).
25. Chen Y., Goldstein J. A., Curr. Drug. Metab., 10, 567-578 (2009).
26. Wrighton S. A., Stevens J. C., Becker G. W., Vanden Branden M., Arch. Biochem. Biophys., 306, 240-245 (1993).
27. Wortham M., Czerwinski M., He L., Parkinson A., Wan Y. J., Drug Metab. Dispos., 35, 1700-1710 (2007).
28. Koop D. R., Tierney D. J., Bioessays, 12, 429-435 (1990).
29. Goldstein J. A., Faletto M. B., Romkes-Sparks M., Sullivan T., Kitareewan S., Raucy J. L., Lasker J. M., Ghanayem B. I., Biochemistry, 33, 1743-1752 (1994).
30. Venkatakrishnan K., von Moltke L. L., Court M. H., Harmatz J. S., Crespi C. L., Greenblatt D. J., Drug Metab. Dispos., 28, 1493-1504 (2000).
31. Shimizudani T., Nagaoka K., Hanioka N., Yamano S., Narimatsu S., Chem. Biol. Interact., 183, 67-78 (2010).